Abbott is an Illinois-based healthcare company that develops and markets medical devices in fields such as neuroscience and diabetes.

Global Strategic Product Manager, Hemodynamic Management ( Pleasanton, CA_

Senior Global Service Professional

Principal Data Engineer

Account Manager, Coronary - Minneapolis/Dakotas

Abbott

Technician

PHARMA

employ

Regional Distribution Sales Manager

Instrumentation Engineer

Service Engineer

Trainee Electrical Engineer

Director, Leadless Technology

Regional Sales Director, Cardiac Arrhythmias

Territory Manager, CRM/EP

Direct Sales Representative

Electrophysiology Technical Service Specialist

Technical Service Specialist, Sr.

SCM Customer Service Specialist

Global Service Parts Operation Specialist

SCM Customer Service Officer

Logistics Assistant Manager

Retail Project Planner

E-Commerce Assistant Manager

B2B Online Sales Intern

Akamai DNS

Route 53

Microsoft Office 365

Amazon AWS

Omniture (Adobe)

Amazon SES

Product Surveillance Specialist II

Biocon: Enhancing Global HealthcareBiocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global healthcare through innovative and affordable biopharmaceuticals, we have enabled access to advanced therapies for diseases that are chronic, where medical needs are largely unmet and treatment costs are high. The early anticipation of the increasing dominance of biologics in global development pipelines helped us to be ahead of the curve in crafting a differentiated product portfolio based on fermentation and recombinant technologies, which straddles fermentation-derived small molecules and biologics, both novel as well as biosimilars.The significant brand equity that we have built worldwide for our small molecule APIs across statins, immunosuppresants and other specialty products has made us a leading global supplier of these products.We have also built one of the largest and most diverse biosimilar pipelines, spanning insulins, monoclonal antibodies and other recombinant proteins that address critical chronic diseases such as diabetes, cancer and autoimmune disorders.Ranked among the Top 3 biosimilar players globally for rh-insulin and insulin glargine in volume terms, we are the first Indian company to launch a biosimilar in Japan with Insulin Glargine, which also has been approved for sale in EU and Australia. Our insulin products have made a difference to the lives of millions of people with diabetes across the globe. We now aim to provide our insulin products to ‘one in five' people with diabetes in need of insulin-based therapy anywhere in the world within the next 10 years.We are also making a huge impact in the area of cancer care. Our biosimilar Trastuzumab, which was the first to be approved anywhere in the world and launched in India in 2014, has helped treat several thousand HER2-positive metastatic breast cancer patients. We are also the first company from India to get its biosimilar approved by the USFDA; Ogivri™, co-developed by Biocon and Mylan, is the first biosimilar Trastuzumab to be approved in the US. In addition to Trastuzumab, several of our biosimilar assets are on track for anticipated regulatory approvals in developed markets.We are also developing a pipeline of patented biologics to address global unmet medical needs. We have successfully launched a couple of novel biologics in India: Nimotuzumab for the treatment of head and neck cancer and Itolizumab to tackle psoriasis. Besides these, we have a basket of novel assets are under various stages of clinical development, including a high potential oral insulin.Through our subsidiary, Syngene, we offer a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) to the global life sciences sector.Ranked by the prestigious Science magazine among the Top 10 Best employers in the biotech industry, Biocon is passionately pursuing a mission to rationalize healthcare spends, enhance access to life-saving therapies and make a significant impact to global healthcare through ‘blockbuster' drugs with the potential to benefit a billion patients.

Komathy Olaganathan

Product Surveillance Specialist II at Abbott

Komathy Olaganathan's Professional Contact Details

Komathy Olaganathan's Current Company Details

Abbott

Komathy Olaganathan's Work History and Education

Frequently Asked Questions about Komathy Olaganathan

What company does Komathy Olaganathan work for?

What is Komathy Olaganathan's role at Abbott?

What is Komathy Olaganathan's email address?

What is Komathy Olaganathan's business email address?

What is Komathy Olaganathan's HQ phone number?

What industry does Komathy Olaganathan work in?

Who are Komathy Olaganathan's colleagues?

Colleagues at Abbott

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?